Rotavirus Gastroenteritis
📧 Sign up to get email alerts when something new happens for Rotavirus Gastroenteritis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-04EMA Authorised: Rotarix (human rotavirus, live attenuated) — GlaxoSmithKline Biologicals S.A.
Rotarix, a live attenuated human rotavirus vaccine, has been authorised for use in the European Union to prevent rotavirus infections.
-
EMA approval · 2026-04-22EMA Authorised: Rotarix (human rotavirus, live attenuated) — GlaxoSmithKline Biologicals S.A.
The European Medicines Agency authorised Rotarix, a live attenuated human rotavirus vaccine, for active immunization against rotavirus infec…
-
EMA approval · 2025-12-18EMA Authorised: RotaTeq (rotavirus serotype G1;rotavirus serotype G2;rotavirus serotype G3;rotavirus serotype G4;rotavirus serotype P1) — Merck Sharp & Dohme B.V.
The EMA authorised RotaTeq (pentavalent rotavirus vaccine) by Merck Sharp & Dohme B.V. for immunization against rotavirus infections. This m…
-
EMA approval · 2010-09-23European Medicines Agency confirms positive benefit-risk balance of RotaTeq
The EMA confirms a positive benefit-risk balance for RotaTeq, supporting its continued use.
-
EMA approval · 2010-07-22European Medicines Agency confirms positive benefit-risk balance of Rotarix
The EMA confirms a positive benefit–risk balance for Rotarix, supporting its continued use and approval status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.